2025年10月31日，通达创智(001368.SZ)发布2025年第三季报。截至2025年10月30日，共有3个机构投资 者披露持有通达创智A股股份，合计持股量达7616.79万股，占通达创智总股本的66.91%。其中，机构 投资者包括通達現代家居(香港)有限公司、通达(厦门)科技投资有限公司、中国建设银行股份有限公司- 诺安多策略混合型证券投资基金，机构投资者合计持股比例达66.91%。相较于上一季度，机构持股比 例合计下跌了0.07个百分点。 公募基金方面，本期较上一季度新披露的公募基金共计1个，即诺安多策略混合A。本期较上一季未再 披露的公募基金共计26个，主要包括国联智选先锋股票A、摩根红利优选股票A、西部利得量化优选一 年持有期混合A、中欧小盘成长混合A、中信建投睿利A等。 ...

Group 1 - The core point of the article is that Fengzhu Textile (600493.SH) reported its Q3 2025 results, indicating a decline in institutional ownership and changes in public fund disclosures [1] Group 2 - As of October 30, 2025, there is one institutional investor holding shares in Fengzhu Textile, with a total holding of 2.4619 million shares, representing 0.91% of the total share capital [1] - The institutional ownership ratio decreased by 0.45 percentage points compared to the previous quarter [1] - One new public fund was disclosed during this period, namely the Nuoan Multi-Strategy Mixed A fund, while 22 public funds were no longer disclosed, including notable funds such as Huaxia Pantai Mixed (LOF) A and CITIC Prudential Multi-Strategy Mixed (LOF) A [1]

外资态度来看，本期较上一季度新披露的外资机构有 1 家 ，即J.P.Morgan Securities PLC-自有资金。 2025年10月30日，天鹅股份(603029.SH)发布2025年第三季报。截至2025年10月29日，共有6个机构投资 者披露持有天鹅股份A股股份，合计持股量达7280.02万股，占天鹅股份总股本的60.00%。其中，机构 投资者包括山东省供销集团有限公司、中国建设银行股份有限公司-诺安多策略混合型证券投资基金、 中国工商银行股份有限公司-中信保诚多策略灵活配置混合型证券投资基金(LOF)、J.P.Morgan Securities PLC-自有资金、中国平安人寿保险股份有限公司-新分红8号-委托(交行)、汇安多策略混合A，机构投资 者合计持股比例达60.00%。相较于上一季度，机构持股比例合计下跌了0.45个百分点。 公募基金方面，本期较上一期持股增加的公募基金共计1个，即诺安多策略混合A，持股增加占比达 0.16%。本期较上一季度持股减少的公募基金共计1个，即中信保诚多策略混合(LOF)A，持股减少占比 达0.91%。本期较上一季度新披露的公募基金共计1个，即汇安多策略混合A。本 ...

Group 1 - Xunlong Holdings (000955.SZ) released its Q3 2025 report on October 28, 2025, indicating that as of October 27, 2025, nine institutional investors disclosed holding a total of 162 million shares, accounting for 30.11% of the total share capital [1] - The institutional investors include notable firms such as Jiaxing Tiantang Silicon Valley Equity Investment Co., Hainan Zhuhua Science and Technology Trade Co., and China Construction Bank Co., among others [1] - Compared to the previous quarter, the total institutional holding percentage increased by 3.23 percentage points [1] Group 2 - In the public fund sector, one public fund, Nuon An Multi-Strategy Mixed A, increased its holdings by 0.24% compared to the previous period [2] - One new public fund, Hai Fu Tong Zhong Zheng 2000 Enhanced Strategy ETF, was disclosed this quarter [2] - Eighteen public funds were not disclosed this quarter, including notable funds such as Guojin Quantitative Multi-Factor A and Western Li De Quantitative Preferred One-Year Holding Period Mixed A [2]

Core Viewpoint - Xinan Technology (301170.SZ) reported its Q3 2025 results, highlighting a decrease in institutional ownership and changes in public fund holdings [1] Institutional Holdings - As of October 27, 2025, five institutional investors disclosed holdings in Xinan Technology, totaling 3.9024 million shares, which represents 3.90% of the company's total share capital [1] - The institutional ownership decreased by 1.69 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, Zhongjia Specialized New Quantitative Stock Mixed Initiation A, increased its holdings by 0.27% compared to the previous period [1] - One new public fund, Nuoan Multi-Strategy Mixed A, was disclosed this quarter [1] - A total of 50 public funds were not disclosed this quarter, including notable funds such as Huaxia Zhisheng New Sharp Stock A and GF Baifa Big Data Growth Mixed A [1] Foreign Investment - One foreign institution, BARCLAYS BANK PLC, was not disclosed in this quarter compared to the previous quarter [1]

Group 1 - Central viewpoint: Several mutual funds in China are implementing purchase limits to ensure stable operations and protect the interests of fund shareholders [1][2][7] - The China Europe Fund announced a limit of 100,000 yuan for the China Europe Medical Innovation fund managed by manager Ge Lan, effective from August 11 [1] - The China Europe Science and Technology Innovation fund managed by manager Shao Jie also announced a limit of 1 million yuan, effective from the same date [2] Group 2 - As of August 6, the China Europe Medical Innovation fund achieved a one-year return of 85.03%, ranking in the top 2 of its category [2] - The China Europe Science and Technology Innovation fund reported a one-year return of 88.5%, also ranking in the top 2 [2] - Approximately 50 actively managed equity funds have announced purchase limits since the beginning of the second half of the year, reflecting a trend in the domestic equity market [2][7] Group 3 - The strong performance of the Hong Kong innovative pharmaceutical sector has been a key driver for the "doubling funds" [3] - Several funds, including the China Hong Kong Pharmaceutical Fund, have reported year-to-date net value growth rates exceeding 100% [3] - QDII funds with excellent market returns are also announcing restrictions on large purchases and regular investment plans [5][6] Group 4 - The main reasons for these purchase restrictions include protecting the interests of fund shareholders and ensuring stable fund operations [7] - Industry experts believe that proactive purchase limits during favorable market conditions can help maintain the effectiveness of investment strategies and protect existing shareholders' interests [7]